Basic Medical Information |
Common Brand Name |
Altace |
Capoten |
Drug Class |
Ace Inhibitors |
Ace Inhibitors |
Legal Status |
Pom (uk), Rx-only (us) |
Rx -only |
Possible Side Effects |
Low Blood Sugar, Dry Cough, Dizziness, Tiredness, Mouth Dryness, Nausea, Vomiting, Diarrhea, Fainting, Change In Amount Of Urine, Yellowing Of Eyes Or Skin, Dark Urine, Abdominal Pain, Neutropenia, Impotence |
Dizziness, Lightheadedness, Loss Of Appetite, Dry Cough, Fainting, Fast Heartbeat, Muscle Weakness, Fever, Chills, Sore Throat, Liver Disease, Abdominal Pain, Skin Rashes |
Precautions & Contraindications |
Angina, Atherosclerosis, Mitral Insufficiency, Renovascular Hypertension, Diabetic Or Nondiabetic Nephropathy, Erythrocytosis |
Aortic Stenosis, Cirrhosis, Kidney Disease, Diabetes, Scleroderma, Lupus Erythematosus, Swelling, Allergies, Pregnant, Breastfeeding |
Excretion |
Renal, Fecal |
Renal |
|
Dosage, Usage and Forms |
Route of Administration |
Oral |
Oral |
Dosage |
2.5 Mg |
25 Mg |
Maximum daily dose |
20 mg |
450 mg |
Forms |
Capsule |
Tablet |
Tablet Formulations |
|
12.5 Mg, 25 Mg, 50 Mg, 100 Mg |
Capsule Formulations |
1.25 Mg, 2.5 Mg, 5 Mg, 10 Mg |
|
Chemical Data |
Molecular mass (g/mol) |
416.51 g/mol |
217.29 g/mol |
Half Life (hours) |
4 |
1.9 |
Chemicals |
Carbon, Hydrogen, Nitrogen, Oxygen |
Carbon, Hydrogen, Nitrogen, Oxygen, Sulfur |
Formula |
C23h32n2o5 |
C9h15no3s |
Melting Point (C) |
109 C |
106 C |
Phase (solid/liquid) |
Solid |
Solid |